The Clarify Project is participating at ESMO Congress, the largest cancer research event in Europe, holding this week.

Clarify presents a poster with data on the influence of family cancer history and lung cancer risk. The study has analysed 12,351 patients with lung cancer diagnosed between August 2016 and June 2020 from the Registry of Thoracic Tumors (RTT) of the Spanish Lung Cancer Group,  (SLCG) Clarify’s partner.

Clarify Partners Dr. Virginia Calvo, from the Puerta de Hierro University Hospital (HUPHM), Madrid, Spain, Emetis Niazmand and Sameneh Jozashoori from Technische Informationsbibliothek (TIB), Hannover, Germany, among the principal investigators of the study.